Endourologic management of upper tract transitional cell carcinoma

Clark PE, Peter E Clark, Stevan B Streem, Streem SB
TheScientificWorldJournal · 2004 · vol. 4 Suppl 1 , pp. 62–75 · doi:10.1100/tsw.2004.49 · PMID:15349530 · PMC5956511
Review OA: gold CC-BY-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-06 ⓘ

The paper discusses the endourologic management of upper tract transitional cell carcinoma, with no abstract available to provide specific findings or details regarding its relation to endometriosis or adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Antineoplastic Agents Carcinoma, Transitional Cell Carcinoma, Transitional Cell Hysteroscopy Laser Therapy Urologic Neoplasms Urologic Neoplasms Administration, Topical Antineoplastic Agents Carcinoma, Transitional Cell Humans Hysteroscopy Laser Therapy Practice Patterns, Physicians' Treatment Outcome Urologic Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:02:42.299833+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC